Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytodyn Inc (OP: CYDY ) 0.1175 UNCHANGED Streaming Delayed Price Updated: 3:58 PM EST, Nov 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cytodyn Inc < Previous 1 2 3 4 Next > CytoDyn Comments on Rosenbaum/Patterson Activist Group “Plan” September 29, 2021 From CytoDyn Inc. Via Business Wire Group of CytoDyn Stockholders Releases White Paper Regarding Company’s Extremely Unfavorable Borrowing Practices September 27, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire CytoDyn to Present at Emerging Growth Conference on September 29 Followed by Live Q/A September 27, 2021 From CytoDyn Inc. Via Business Wire Group of CytoDyn Stockholders Shares Strategic Plan to Obtain Cancer Therapy Approval for Leronlimab September 24, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants September 22, 2021 Via FinancialNewsMedia Exposures COVID-19 CytoDyn Receives Clearance from Brazil’s FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week) September 22, 2021 From CytoDyn Inc. Via Business Wire CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021 September 21, 2021 From CytoDyn Inc. Via Business Wire Group of CytoDyn Stockholders Announces Federal Court Dismisses Litigation Brought by Company September 20, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire CytoDyn Announces Resolution of Federal Litigation with Rosenbaum/Patterson Activist Group September 20, 2021 From CytoDyn Inc. Via Business Wire Bruce Patterson, M.D., Director Candidate for CytoDyn Board, Presents at International COVID Summit September 17, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire Glancy Prongay & Murray LLP Announces Investigation of CytoDyn Inc. September 15, 2021 From Glancy Prongay & Murray LLP Via Business Wire Why Experts Believe Antibody Treatments Hold The Potential To Reduce Need For Hospitalization For COVID-19 Patients September 14, 2021 Via FinancialNewsMedia Exposures COVID-19 Group of CytoDyn Stockolders Responds to Misleading Company News Release September 07, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test September 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... Via Benzinga CytoDyn Highlights Court Ordering Rosenbaum/Patterson Group to Comply With the Federal Securities Laws September 02, 2021 From CytoDyn Inc. Via Business Wire Group of CytoDyn Stockholders Warns Stockholders of Board’s Continued Value Destruction and Failures September 02, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire Group of CytoDyn Stockholders Files Lawsuit to Force Company to Allow Stockholders to Vote for Alternative Director Nominees August 26, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire CytoDyn Urges Shareholders to Ignore Proxy Cards from Rosenbaum/Patterson Group August 25, 2021 From CytoDyn Via Business Wire Group of CytoDyn Stockholders Responds to Highly Misleading Company Release August 19, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire CytoDyn Provides Update on Rosenbaum/Patterson Group Litigation August 19, 2021 From CytoDyn Inc. Via Business Wire CytoDyn Files Lawsuit Against Rosenbaum/Patterson Activist Group for Misleading Shareholders and Waging an Unlawful Proxy Contest August 05, 2021 From CytoDyn Inc. Via Business Wire CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients August 03, 2021 From CytoDyn Inc. Via Business Wire CytoDyn Announces That Director Nominations by Rosenbaum/Patterson Activist Group Are Invalid August 02, 2021 From CytoDyn Inc. Via Business Wire CytoDyn Inc. (OTC: CYDY) Long Term Investor Notice: Investigation of Potential Wrongdoing July 28, 2021 San Diego, CA -- (SBWIRE) -- 07/28/2021 -- An investigation on behalf of current long term investors in CytoDyn Inc. (OTC: CYDY) shares over possible breaches of fiduciary duty by certain officers and... Via SBWire Topics Lawsuit Exposures COVID-19 Financial Legal OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities July 28, 2021 Photo by Kyrie Kim on Unsplash In a similar vein to 2020, the market’s volatility to start 2021 gave way to less volatility in the second quarter, and even less volatility... Via Benzinga Group of Cytodyn Stockholders Nominates Five Highly Qualified Director Candidates to Replace Board Responsible for Mismanagement and Value Destruction July 01, 2021 From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders Via Business Wire What's Behind This Wild-Card Coronavirus Stock? June 08, 2021 Failure is not an option for this small-cap biotech developing a COVID-19 treatment. Via The Motley Fool Exposures COVID-19 CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines May 18, 2021 After facing rebuke from FDA, CytoDyn Inc (OTC: CYDY) plans to submit the topline results of its CD12 Phase 3 trial of Vyrologix (leronlimab-PRO 140... Via Benzinga Exposures COVID-19 Product Safety CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment May 18, 2021 The FDA has accused CytoDyn Inc (OTC: CYDY) of trying to pick and choose data from two failed studies of leronlimab in COVID-19 patients to claim the drug is... Via Benzinga Exposures COVID-19 Product Safety The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO May 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
